A phospholipase Cγ1-activated pathway regulates transcription in human vascular smooth muscle cells

Cardiovascular Research

Volumn 90, Issue 3, 2011, Pages 557-564

  Hunter, Irene ^a   Mascall, Keith S ^a   Ramos, Joe W ^b   Nixon, Graeme F ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

Mitogen activated protein kinase; Phospholipase C; Transcription; Vascular smooth muscle

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHOLIPASE C GAMMA1; PLATELET DERIVED GROWTH FACTOR; TRANSCRIPTION FACTOR ELK 1;

ARTICLE; ASTROCYTE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; GENE EXPRESSION; GENE OVEREXPRESSION; GENE REPRESSION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SMOOTH MUSCLE FIBER; TRANSCRIPTION REGULATION; VASCULAR SMOOTH MUSCLE;

ACTINS; ACTIVE TRANSPORT, CELL NUCLEUS; CELLS, CULTURED; ETS-DOMAIN PROTEIN ELK-1; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAP KINASE SIGNALING SYSTEM; MYOCYTES, SMOOTH MUSCLE; PHOSPHOLIPASE C GAMMA; PHOSPHOPROTEINS; PHOSPHORYLATION; PLATELET-DERIVED GROWTH FACTOR; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 79957457340     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr039     Document Type: Article

References (28)

1. Wamhoff BR, Bowles DK, Owens GK. Excitation-transcription coupling in arterial smooth muscle. Circ Res 2006;98:868-878.
2. Kaplan-Albuquerque N, Bogaert YE, Van Putten V, Weiser-Evans MC, Nemenoff RA. Patterns of gene expression differentially regulated by PDGF and hypertrophic stimuli in vascular smooth muscle. J Biol Chem 2005;280:19966- 19976.
3. Kawai-Kowase K, Owens GK. Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells. Am J Physiol Cell Physiol 2007;292: C59-C69. (Pubitemid 46127305)
4. Wang Z, Whang D-Z, Hockmeyer D, McAnally J, Nordheim A, Olson EN. Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression. Nature 2004;428:185-189. (Pubitemid 38374315)
5. Zhou J, Hu G, Herring BP. Smooth muscle-specific genes are differentially sensitive to inhibition by Elk-1. Mol Cell Biol 2005;25:9874-9885. (Pubitemid 41572736)
6. Miano JM. Serum response factor: Toggling between disparate programs of gene expression. J Mol Cell Cardiol 2003;35:577-593. (Pubitemid 36681543)
7. Khachigian LM. Early growth response-1 in cardiovascular pathobiology. Circ Res 2006; 98:186-191.
8. Pouysségur J, Volmat V, Lenormand P. Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling. Biochem Pharmacol 2002;64:755-763. (Pubitemid 35238027)
9. Ramos JW. The regulation of extracellular signal-regulated kinase in mammalian cells. Int J Biochem Cell Biol 2008;40:2707-2719.
10. Morrison DK, Davis RJ. Regulation of MAP kinase signaling modules by scaffold proteins in mammals. Annu Rev Cell Dev Biol 2003;19:91-118. (Pubitemid 37487344)
11. Bharadwaj S, Vasanth G, Masuelli L, Thanawala R, Prasad GL. Inhibition of nuclear accumulation of phosphorylated ERK by tropomyosin-1-mediated cytoskeletal reorganization. J Cancer Mol 2008;5:139-144.
12. Rhee SG. Regulation of phosphoinositide-specific phospholipase C. Annu Rev Biochem 2001;70:281-312. (Pubitemid 32662212)
13. 2+ regulation. Cardiovasc Res 2005;67:308-316. (Pubitemid 40943624)
14. Formstecher E, Ramos JW, Fauquet M, Calderwood DA, Hsieh JC, Canton B et al. PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase. Dev Cell 2001;1: 239-250. (Pubitemid 33653059)
15. Hunter I, Nixon GF. Spatial compartmentalization of tumor necrosis factor (TNF) receptor 1-dependent signaling pathways in human airway smooth muscle cells. Lipid rafts are essential for TNF-a-mediated activation of RhoA but dispensable for the activation of the NF-kB and MAPK pathways. J Biol Chem 2006;281:34705-34715. (Pubitemid 46036676)
16. Renganathan H, Vaidyanathan H, Knapinska A, Ramos JW. Phosphorylation of PEA-15 switches its binding specificity from ERK/MAPK to FADD. Biochem J 2005;390: 729-735. (Pubitemid 41395356)
17. Krueger J, Chou FL, Glading A, Schaefer E, Ginsberg MH. Phosphorylation of phosphoprotein enriched in astrocytes (PEA-15) regulates extracellular signal-regulated kinase-dependent transcription and cell proliferation. Mol Biol Cell 2005;16: 3552-3561. (Pubitemid 41077069)
18. Kubes M, Cordier J, Glowinski J, Girault JA, Chneiweiss H. Endothelin induces a calcium-dependent phosphorylation of PEA-15 in intact astrocytes: Identification of Ser104 and Ser116 phosphorylated, respectively, by protein kinase C and calcium/calmodulin kinase II in vitro. J Neurochem 1998;71:1307-1314. (Pubitemid 28390286)
19. Estellés A, Yokoyama M, Nothias F, Vincent JD, Glowinski J, Vernier P et al. The major astrocytic phosphoprotein PEA-15 is encoded by two mRNAs conserved on their full length in mouse and human. J Biol Chem 1996;271:14800-14806. (Pubitemid 26194960)
20. Ramos JW, Kojima TK, Hughes PE, Fenczik CA, Ginsberg MH. The death effector domain of PEA-15 is involved in its regulation of integrin activation. J Biol Chem 1998;273:33897-33900. (Pubitemid 29008850)
21. Kitsberg D, Formstecher E, Fauquet M, Kubes M, Cordier J, Canton B et al. Knock-out of the neural death effector domain protein PEA-15 demonstrates that its expression protects astrocytes from TNFalpha-induced apoptosis. J Neurosci 1999;19: 8244-8251. (Pubitemid 30226743)
22. Trencia A, Perfetti A, Cassese A, Vigliotta G, Miele C, Oriente F et al. Protein kinase B/Akt binds and phosphorylates PED/PEA-15, stabilizing its antiapoptotic action. Mol Cell Biol 2003;23:4511-4521. (Pubitemid 36734742)
23. Hill JM, Vaidyanathan H, Ramos JW, Ginsberg MH, Werner MH. Recognition of ERK MAP kinase by PEA-15 reveals a common docking site within the death domain and death effector domain. EMBO J 2002;21:6494-6504. (Pubitemid 35448427)
24. Whitehurst AW, Robinson FL, Moore MS, Cobb MH. The death effector domain protein PEA-15 prevents nuclear entry of ERK2 by inhibiting required interactions. J Biol Chem 2004;279:12840-12847. (Pubitemid 38445857)
25. Vaidyanathan H, Opoku-Ansah J, Pastorino S, Renganathan H, Matter ML, Ramos JW. ERK MAP kinase is targeted to RSK2 by the phosphoprotein PEA-15. Proc Natl Acad Sci USA 2007;104:19837-19842.
26. Pastorino S, Renganathan H, Caliva MJ, Filbert EL, Opoku-Ansah J, Sulzmaier FJ et al. The death effector domain protein PEA-15 negatively regulates T-cell receptor signaling. FASEB J 2010;24:2818-2828.
27. Ungaro P, Teperino R, Mirra P, Cassese A, Fiory F, Perruolo G et al. Molecular cloning and characterization of the human PED/PEA-15 gene promoter reveal antagonistic regulation by hepatocyte nuclear factor 4alpha and chicken ovalbumin upstream promoter transcription factor II. J Biol Chem 2008;283:30970-30979.
28. Condorelli G, Vigliotta G, Iavarone C, Caruso M, Tocchetti CG, Andreozzi F et al. PED/PEA-15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus. EMBO J 1998;17:3858-3866. (Pubitemid 28333972)